Identification of Residues Required for RNA Replication in Domains II and III of the Hepatitis C Virus NS5A Protein
about
Intrinsically unstructured domain 3 of hepatitis C Virus NS5A forms a "fuzzy complex" with VAPB-MSP domain which carries ALS-causing mutationsHepatitis C virus NS5B and host cyclophilin A share a common binding site on NS5ARole of ledipasvir/sofosbuvir combination for genotype 1 hepatitis C virus infectionChaperones in hepatitis C virus infectionRegulation of Hepatitis C Virion Production via Phosphorylation of the NS5A ProteinEssential Role of Domain III of Nonstructural Protein 5A for Hepatitis C Virus Infectious Particle AssemblyInteraction of Hepatitis C Virus Nonstructural Protein 5A with Core Protein Is Critical for the Production of Infectious Virus ParticlesHigh-Resolution Functional Profiling of Hepatitis C Virus GenomeRole of the Hepatitis C Virus Core+1 Open Reading Frame and Core cis-Acting RNA Elements in Viral RNA Translation and ReplicationA Cooperative Interaction between Nontranslated RNA Sequences and NS5A Protein Promotes In Vivo Fitness of a Chimeric Hepatitis C/GB Virus BCrystal Structure of a Novel Dimeric Form of NS5A Domain I Protein from Hepatitis C VirusHepatitis C Virus NS5A Protein Is a Substrate for the Peptidyl-prolyl cis/trans Isomerase Activity of Cyclophilins A and BThe Marmoset Model of GB Virus B Infections: Adaptation to Host Phenotypic VariationProduction of Infectious Genotype 1b Virus Particles in Cell Culture and Impairment by Replication Enhancing MutationsHepatitis C virus NS4B carboxy terminal domain is a membrane binding domainThe Hepatitis C Virus NS5A Stimulates NS5B During In Vitro RNA Synthesis in a Template Specific MannerA Conserved Proline between Domains II and III of Hepatitis C Virus NS5A Influences both RNA Replication and Virus AssemblyArchitects of assembly: roles of Flaviviridae non-structural proteins in virion morphogenesisCyclosporine Inhibits a Direct Interaction between Cyclophilins and Hepatitis C NS5AThe crystal structure of NS5A domain 1 from genotype 1a reveals new clues to the mechanism of action for dimeric HCV inhibitorsSeed Sequence-Matched Controls Reveal Limitations of Small Interfering RNA Knockdown in Functional and Structural Studies of Hepatitis C Virus NS5A-MOBKL1B InteractionMetabolism of phosphatidylinositol 4-kinase IIIα-dependent PI4P Is subverted by HCV and is targeted by a 4-anilino quinazoline with antiviral activityDEB025 (Alisporivir) inhibits hepatitis C virus replication by preventing a cyclophilin A induced cis-trans isomerisation in domain II of NS5AThe Disordered Region of the HCV Protein NS5A: Conformational Dynamics, SH3 Binding, and PhosphorylationVAPC, an human endogenous inhibitor for hepatitis C virus (HCV) infection, is intrinsically unstructured but forms a "fuzzy complex" with HCV NS5B.A major determinant of cyclophilin dependence and cyclosporine susceptibility of hepatitis C virus identified by a genetic approachSmall molecules targeting hepatitis C virus-encoded NS5A cause subcellular redistribution of their target: insights into compound modes of action.Hepatitis C virus NS5A hijacks ARFGAP1 to maintain a phosphatidylinositol 4-phosphate-enriched microenvironmentHepatitis C virus NS5A activates the mammalian target of rapamycin (mTOR) pathway, contributing to cell survival by disrupting the interaction between FK506-binding protein 38 (FKBP38) and mTORResistance analysis of the hepatitis C virus NS5A inhibitor BMS-790052 in an in vitro replicon system.Modeling shows that the NS5A inhibitor daclatasvir has two modes of action and yields a shorter estimate of the hepatitis C virus half-lifeEthanol and reactive species increase basal sequence heterogeneity of hepatitis C virus and produce variants with reduced susceptibility to antivirals.Heat shock protein 72 is associated with the hepatitis C virus replicase complex and enhances viral RNA replication.All three domains of the hepatitis C virus nonstructural NS5A protein contribute to RNA binding.Distinct functions of NS5A in hepatitis C virus RNA replication uncovered by studies with the NS5A inhibitor BMS-790052Cyclophilin A associates with enterovirus-71 virus capsid and plays an essential role in viral infection as an uncoating regulatorAnalysis of functional differences between hepatitis C virus NS5A of genotypes 1-7 in infectious cell culture systems.Hepatitis C NS5A protein: two drug targets within the same protein with different mechanisms of resistance.A cell culture adapted HCV JFH1 variant that increases viral titers and permits the production of high titer infectious chimeric reporter viruses.Comparison of the Mechanisms of Drug Resistance among HIV, Hepatitis B, and Hepatitis C.
P2860
Q21560973-CF80E681-A4B3-4A4F-979E-4F5263B2B705Q24303838-57945B08-CB26-483F-89A9-22145EFEE509Q26740216-6108CE80-6411-4844-9F59-3557A35D050BQ26771251-9DEE4AB5-2B84-42CE-BE14-525FE6390B8AQ27485476-4F0D2193-2428-4ABE-9D53-4D5531CA4726Q27485487-EF36D5C7-0EB3-4229-895C-7CE4060CA810Q27486780-EBD939AC-DE1B-4436-B9D3-90305E69EEAEQ27487019-ACFE79FE-3B09-49E8-BC7C-D6A78081E016Q27487337-9BCD4718-C20A-42CC-B22E-6976A66F8DF7Q27487865-5AB82FCA-0248-4328-86DA-C5B78052DFA0Q27488306-92201DB0-3AD9-4F1F-BD5A-E34D10E284E6Q27488369-99CD3DC8-B939-4590-BFED-769E17003784Q27488391-2ECDF336-121B-4E30-93B9-EA67A8ECECDCQ27488616-3520352F-5E10-46F3-BFE4-2D89C2DFE95BQ27488808-FBA9CBAD-B2EF-479C-B9BC-BF5ADDC8E492Q27488841-C7056463-A2C3-4843-B891-4660185C4E5FQ27489795-DDF4E721-A984-4F48-B899-8056CDCED249Q27490193-A5FAA2EF-6B41-478C-98AE-6EB6E84C8952Q27491303-275DE7F6-1FB3-4856-BFB8-DDAE175AABFEQ27682272-86389B3A-D716-4930-A5BE-956560EFA87FQ27684710-452417D3-BA5B-4A5E-AC9D-5A476E262C7CQ28481438-7B726A5D-686C-4E8D-B692-9DB554A47315Q28748683-34348E2A-218B-4FA1-B52C-77D89D34A637Q30009088-4977B501-1F16-43C7-B576-05696975D5F7Q30155273-A6C46AAE-7528-47FA-9882-6933DDD79F2AQ33707739-B2149C9E-0B3C-4A22-B09E-9C5BC1FA41C5Q33878202-45A09CCA-C4AA-4734-96FF-E7EA02FE4932Q33887705-BA697875-3255-40FF-8691-53BA94DC43AFQ33966987-F34AB7AA-3528-4FE9-8E69-3AD507FFDC29Q34022926-A436269C-E7C8-45A4-AFB1-217B8B56DC8BQ34035703-90B48BB0-DFD0-4538-B2BB-E1DDC02D1668Q34075689-F3C209B8-C8A0-4DA1-BB78-1D3FF8D821D0Q34107435-6E8BF527-5C6B-4D1E-B462-CD41C0069586Q34120165-4617D2C5-71D3-434D-AB65-E9A2D6145FA9Q34185949-EC14B498-4739-464E-B040-FCD92909C2A9Q34282430-769B07E6-3991-46D0-9E95-D72E5CBAF801Q34288777-1BE30156-B95C-4D38-8FC3-646F7D0A4DC8Q34332546-DB3553B2-7435-4D7B-988F-BD6EF0A4A584Q34427768-F9F22761-B42E-4D43-8EE4-51D7670A6B33Q34489239-592A0610-323B-4895-B886-12F420677BF9
P2860
Identification of Residues Required for RNA Replication in Domains II and III of the Hepatitis C Virus NS5A Protein
description
2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
article scientifique (publié 2008-02)
@fr
articolo scientifico (pubblicato il 2008-02)
@it
artigo científico (publicado na 2008-02)
@pt
artículu científicu espublizáu en 2008
@ast
im Februar 2008 veröffentlichter wissenschaftlicher Artikel
@de
scientific article (publication date: February 2008)
@en
vedecký článok (publikovaný 2008-02)
@sk
videnskabelig artikel (udgivet 2008-02)
@da
name
Identification of Residues Req ...... Hepatitis C Virus NS5A Protein
@ast
Identification of Residues Req ...... Hepatitis C Virus NS5A Protein
@en
Identification of Residues Req ...... Hepatitis C Virus NS5A Protein
@nl
type
label
Identification of Residues Req ...... Hepatitis C Virus NS5A Protein
@ast
Identification of Residues Req ...... Hepatitis C Virus NS5A Protein
@en
Identification of Residues Req ...... Hepatitis C Virus NS5A Protein
@nl
prefLabel
Identification of Residues Req ...... Hepatitis C Virus NS5A Protein
@ast
Identification of Residues Req ...... Hepatitis C Virus NS5A Protein
@en
Identification of Residues Req ...... Hepatitis C Virus NS5A Protein
@nl
P2093
P2860
P3181
P356
P1433
P1476
Identification of Residues Req ...... Hepatitis C Virus NS5A Protein
@en
P2093
Charles M Rice
Jason C Treadaway
Katie L Foss
Timothy L Tellinghuisen
P2860
P304
P3181
P356
10.1128/JVI.00328-07
P577
2008-02-01T00:00:00Z